Clinical Trial Update: EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance [Phase 2]

View source ↗

Summary

EMPOWIR is a Phase 2 trial evaluating metabolic improvement in women with insulin resistance. The study has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Snippet

Sponsor: New York Medical College | Conditions: Hyperinsulinemia, Insulin Resistance | Phase 2 | Status: COMPLETED | Results posted: 2014-03-28